2-HYDROXYPROPYL-BETA-CYCLODEXTRIN IN TOPICAL CARBONIC-ANHYDRASE INHIBITOR FORMULATIONS

被引:49
作者
LOFTSSON, T
FRITHRIKSDOTTIR, H
THORISDOTTIR, S
STEFANSSON, E
SIGURTHARDOTTIR, AM
GUTHMUNDSSON, O
SIGTHORSSON, T
机构
[1] UNIV ICELAND,FAC MED,DEPT OPHTHALMOL,REYKJAVIK,ICELAND
[2] LYFJAVERSLUN RIKISINS,REYKJAVIK,ICELAND
关键词
ACETAZOLAMIDE; CYCLODEXTRIN; ETHOXYZOLAMIDE; EYE-DROPS; GLAUCOMA; TOPICAL ADMINISTRATION;
D O I
10.1016/0928-0987(94)90001-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of 2-hydroxypropyl-beta-cyclodextrin (HP beta CD) on the permeation of acetazolamide through semi-permeable membrane and the topical delivery of acetazolamide and ethoxyzolamide was investigated. Both the Free drug and the drug-HP beta CD complex permeate a semi-permeable cellophane membrane, but the free drug molecules permeate the membrane at a rate about 24 times faster than the drug-HP beta CD complex. Maximum acetazolamide penetration was obtained when just enough HP beta CD was used to keep all acetazolamide in solution. Only insignificant amounts of HP beta CD are able to permeate tight biological barriers like the eye cornea. Our results indicate that HP beta CD increases the ocular bioavailability of acetazolamide by keeping the acetazolamide molecules in solution and increasing their availability at the surface of the corneal barrier without penetrating the barrier itself In vivo experiments in rabbits showed that topically applied aqueous 1% acetazolamide low viscosity eye-drop solution had notable but somewhat less IOP lowering effect than Blocadren(R).
引用
收藏
页码:175 / 180
页数:6
相关论文
共 20 条
[1]   ACETAZOLAMIDE-LIKE CARBONIC-ANHYDRASE INHIBITORS WITH TOPICAL OCULAR HYPOTENSIVE ACTIVITY [J].
ANTONAROLI, S ;
BIANCO, A ;
BRUFANI, M ;
CELLAI, L ;
BAIDO, GL ;
POTIER, E ;
BONOMI, L ;
PERFETTI, S ;
FIASCHI, AI ;
SEGRE, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (14) :2697-2703
[3]  
FRIEDMAN Z, 1985, ARCH OPHTHALMOL-CHIC, V103, P936
[4]  
GERLOCZY A, 1990, 5 INT S CYCL, P507
[5]   EFFECTS OF LOCALLY ADMINISTERED DIAMOX [J].
GREEN, H ;
LEOPOLD, IH .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1955, 40 (05) :137-139
[6]   OCULAR DISTRIBUTION STUDIES OF THE TOPICAL CARBONIC-ANHYDRASE INHIBITORS L-643,799 AND L-650,719 AND RELATED ALKYL PRODRUGS [J].
GROVE, J ;
GAUTHERON, P ;
PLAZONNET, B ;
SUGRUE, MF .
JOURNAL OF OCULAR PHARMACOLOGY, 1988, 4 (04) :279-290
[7]  
Grove J, 1990, 5 INT S CYCL PAR ED, P479
[8]  
Higuchi T., 1965, PHASE SOLUBILITY TEC, V4, P117
[9]   AMINOZOLAMIDE SUSPENSION - THE ROLE OF THE VEHICLE IN A TOPICAL CARBONIC-ANHYDRASE INHIBITOR [J].
LEWIS, RA ;
SCHOENWALD, RD ;
BARFKNECHT, CF .
JOURNAL OF OCULAR PHARMACOLOGY, 1988, 4 (03) :215-219
[10]  
LOFTSSON T, 1991, EUR J PHARM BIOPHARM, V37, P30